BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16028287)

  • 1. Effect of thalidomide on colorectal cancer liver metastases in CBA mice.
    Daruwalla J; Nikfarjam M; Malcontenti-Wilson C; Muralidharan V; Christophi C
    J Surg Oncol; 2005 Aug; 91(2):134-40. PubMed ID: 16028287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.
    Malcontenti-Wilson C; Chan L; Nikfarjam M; Muralidharan V; Christophi C
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e96-e104. PubMed ID: 17559382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered growth patterns of colorectal liver metastases after thermal ablation.
    Nikfarjam M; Muralidharan V; Christophi C
    Surgery; 2006 Jan; 139(1):73-81. PubMed ID: 16364720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model.
    Malcontenti-Wilson C; Muralidharan V; Skinner S; Christophi C; Sherris D; O'Brien PE
    Clin Cancer Res; 2001 Apr; 7(4):1052-60. PubMed ID: 11309357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in vascular architecture and permeability following OXi4503 treatment.
    Chan LS; Malcontenti-Wilson C; Muralidharan V; Christophi C
    Anticancer Drugs; 2008 Jan; 19(1):17-22. PubMed ID: 18043126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hyperbaric oxygen therapy on tumour growth in a mouse model of colorectal cancer liver metastases.
    Daruwalla J; Christophi C
    Eur J Cancer; 2006 Dec; 42(18):3304-11. PubMed ID: 17010602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the microvascular architecture of colorectal liver metastases following the administration of SMANCS/lipiodol.
    Kuruppu D; Christophi C; Maeda H; O'Brien PE
    J Surg Res; 2002 Mar; 103(1):47-54. PubMed ID: 11855917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy.
    Nikfarjam M; Muralidharan V; Malcontenti-Wilson C; Christophi C
    Lasers Surg Med; 2005 Jul; 37(1):64-73. PubMed ID: 15954121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
    Zhai Y; Lu ZJ
    Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G
    Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
    Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
    Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J; Sarraf-Yazdi S; Zhang X; Cao Y; Dewhirst MW; Kontos CD; Li CY; Clary BM
    J Surg Res; 2006 Mar; 131(1):97-104. PubMed ID: 16242720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice.
    Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N
    Anticancer Res; 2003; 23(3B):2405-11. PubMed ID: 12894521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
    Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
    J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.
    Kaicker S; McCrudden KW; Beck L; New T; Huang J; Frischer JS; Serur A; Kadenhe-Chiweshe A; Yokoi A; Kandel JJ; Yamashiro DJ
    Int J Oncol; 2003 Dec; 23(6):1651-5. PubMed ID: 14612937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.